Symphony Asset Management »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Symphony Asset Management

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Symphony Asset Management from 13F filings

Historical chart of Symphony Asset Management investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Symphony Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Symphony Asset Management

Quarter filed Position value Share count Share price at filing
2020-06-30 $701k 500k 1.40
2020-03-31 $717k 500k 1.43
2019-12-31 $715k 500k 1.43

More positions owned by Symphony Asset Management

Twitter Bond (Principal)
On Semiconductor Corp Bond (Principal)
Iheartmedia SHS (IHRT)
Teva Pharmaceutical Finance Bond (Principal)
8X8 Bond (Principal)
Ligand Pharmaceuticals Bond (Principal)
Zillow Group Bond (Principal)
Fireeye Bond (Principal)
Avaya Holdings Corp SHS
Spdr S&p 500 Etf Trust SHS Put Option (SPY)
Realpage Bond (Principal)
Pluralsight Bond (Principal)
Coupa Software SHS
Liveperson Bond (Principal)
Palo Alto Networks SHS (PANW)

View all positions for Symphony Asset Management

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Birch Grove Capital
Capstone Investment Advisors
Lazard Asset Management
DeepCurrents Investment Group
BLB^B Advisors
Jpmorgan Chase & Co
Context Capital Management

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1